Cowen Downgrades Ionis After Thrombocytopenia Issues
May 26, 2016 at 13:33 PM EDT
Ionis Pharmaceuticals Inc (NASDAQ: IONS) shares are tanking nearly 40 percent on Thursday following the company’s disclosure ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.